Sign in

Brian R. Mueller

Executive Vice President and Chief Financial Officer at BIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICAL
Executive

About Brian R. Mueller

Executive Vice President and Chief Financial Officer of BioMarin; age 51; joined BioMarin in December 2002 after audit leadership roles at Arthur Andersen and KPMG; B.S. in Accountancy (Northern Illinois University); member of the American Institute of CPAs . 2024 corporate performance results that drove incentive pay included total revenue of $2.841B (adjusted), Non-GAAP diluted EPS of $3.29, and an overall annual bonus funding of 130% of target; three-year (2022–2024) performance-based equity payouts reflected strong core operating margin expansion (2.5% → 14.6%) and 71st percentile relative TSR (capped at 100% due to negative absolute TSR) . Say‑on‑pay support was 93% at the most recent vote, indicating broad shareholder alignment on pay design .

Past Roles

OrganizationRoleYearsNotes
BioMarinEVP & CFOCurrentJoined BioMarin Dec 2002; previously CAO (Mar 2011–Jun 2020) and Corporate Controller .
KPMGSenior Manager, Audit2002Joined after Arthur Andersen ceased operations in June 2002 .
Arthur Andersen LLPAudit & Business Advisory~1995–Jun 2002Seven years prior to June 2002 .

External Roles

OrganizationRoleYearsNotes
American Institute of Certified Public AccountantsMembern/aProfessional membership .

Fixed Compensation

  • Base salary set to $705,000 effective March 2024 (up 4.4% vs. 2023); salary actually earned in 2024 was $699,231 (proration/timing) .
  • 2024 annual cash incentive target was 60% of base; individual funding for Mueller set at 145% reflecting contributions to profitability and execution; paid $613,350 in March 2025 .
Compensation Element202220232024
Salary (earned)$624,231 $666,346 $699,231
Bonus (Sign-on/Other)
Stock Awards (RSUs/PSUs, Grant-Date FV)$3,104,558 $2,947,369 $3,199,820
Option Awards (Grant-Date FV)$852,883 $832,004 $963,369
Non-Equity Incentive (Annual Cash)$500,850 $384,750 $613,350
All Other Compensation$24,762 $23,723 $22,798
Total$5,107,284 $4,854,192 $5,498,568
Base Salary Setting20232024
Base Salary$675,000 $705,000
YoY Increase4.4%
Annual Cash Incentive (2024)Target (% base)Individual FundingActual Payout
Brian R. Mueller60% 145% $613,350

Performance Compensation

  • Short-term program emphasized total revenue and Non-GAAP diluted EPS (50% combined weighting) plus development goals (50%); overall corporate funding was 130% of target .
2024 Annual Cash Incentive MetricsWeightTargetResultFunding Pool Contribution
Total Revenue ($M, adjusted)25% $2,810 $2,841 26%
Non-GAAP Diluted EPS25% $3.15 $3.29 32%
Development Goals (Near-term, Mid-term)50% See plan See plan 72% subtotal
Total Corporate Funding100%130%
  • Long-term PSUs earned for 2022–2024 period reflected rTSR at the 71st percentile (payout capped 100% due to negative absolute TSR), core operating margin above target (payout 169.7%), and strategic goals >100% (payout 175%) .
3-Year PSU Performance (2022–2024)Target202220232024Payout
Relative TSR (percentile)50th 71st 100% cap
Core Operating Margin2.0%/yr 2.5% 7.4% 14.6% 169.7%
Strategic Goals100% >100% 175%
  • 2024 Equity Grants (Mueller):
Award (Grant 3/15/2024)QuantityPrice/TermsGrant-Date FV
Stock Options25,540 $83.87; expire 3/14/2034 $963,369
Service-based RSUs11,400 Per award terms $956,118
Performance-based RSUs (Tranche A, target)13,680 Performance-based; target shown $1,478,808
Performance-based RSUs (Tranche B, target)9,120 Performance-based; target shown $764,894

2024 design emphasized rTSR PSUs and removed financial-metric PSUs due to strategic review timing; weighting of short-term financial goals increased to 50% .

Equity Ownership & Alignment

Ownership Snapshot (as of Mar 14, 2025)Count/Status
Shares Beneficially Owned44,898
Shares subject to options/RSUs vesting within 60 days169,644
Total beneficial incl. within‑60‑day214,542
% of Shares Outstanding<1% (star in proxy)
Stock Ownership PolicyDetail
NEO Ownership GuidelineValue of shares + unvested RSUs = 2x base salary
Compliance Status (12/31/2024)All directors and NEOs (except recent joiners) in compliance
Anti‑Hedging / Anti‑PledgingShort sales, options, hedging, margin and pledging prohibited

Selected outstanding equity at FY‑end 2024 (illustrative):

  • Options: 25,540 (3/15/2024, $83.87, exp. 3/14/2034); 23,333 exercisable + 1,557 unexercisable (3/15/2021, $78.39, exp. 3/14/2031); earlier grants with strikes $73.82–$124.37 remain outstanding .
  • RSUs (unvested at 12/31/2024): service‑based 11,400 (2024 grant) and prior blocks (e.g., 7,223 from 2023 grant), plus performance‑based targets (e.g., 9,630; 4,820; 4,820 from 2023; 13,680 and 9,120 from 2024) as disclosed .
  • Valuation reference: $65.73 closing price at 12/31/2024 used for award values; many option exercise prices exceed this level, implying limited near‑term in‑the‑money pressure from options .

Employment Terms

  • Involuntary termination without cause: 150% of current base + target bonus (paid lump sum on 60th day), pro‑rated target bonus for year of termination, 12 months additional vesting credit on unvested equity, 18 months COBRA premiums, and outplacement/legal support .
  • Change‑in‑control (CIC) termination (double trigger): 200% of base + target bonus, pro‑rated target bonus, 100% vesting of unvested service‑based equity and target PSUs, 24 months COBRA, outplacement/legal support; CIC “continued employment” for NEOs (other than CEO) also vests 100% of unvested service‑based and target PSUs (single‑trigger equity vesting) .
  • Estimated payouts (as of 12/31/2024 measurement, BMRN close $65.73):
Scenario (Mueller)Cash SeveranceCash IncentiveEquity AccelerationBenefits/OtherTotal
Involuntary Termination (No CIC)$1,692,000 $423,000 $2,144,507 $110,132 (COBRA + outplacement) $4,369,639
CIC – Continued Employment$5,969,664 $5,969,664
CIC – Terminated$2,256,000 $423,000 $5,969,664 $138,509 (COBRA + outplacement) $8,787,174

Governance protections and policies:

  • Clawback: Dodd‑Frank/Nasdaq‑compliant recoupment policy adopted Oct 4, 2023; applies to incentive‑based compensation upon required restatement .
  • Excise tax gross‑ups: Policy against granting excise tax gross‑ups to executives (adopted March 2015) .
  • Nonqualified deferred compensation: Plan available; 2024 table shows no reported deferral balance for Mueller .

Investment Implications

  • Pay‑for‑performance alignment: High variable pay with explicit revenue and profitability targets; 2024 corporate funding at 130% and Mueller’s individual payout at 145% reflect emphasis on execution and profitability, supporting confidence in financial discipline .
  • Retention/turnover economics: Involuntary and CIC severance structures (150% and 200% of pay, respectively) plus significant equity acceleration ($6.0M under CIC) reduce retention risk and create meaningful “walk‑away” disincentives, but single‑trigger equity vesting upon CIC for NEOs (continued employment) introduces potential deal‑related equity supply overhang .
  • Insider selling pressure: Near‑term vesting/exercisability covers 169,644 shares within 60 days of 3/14/2025, suggesting periodic RSU‑driven settlement needs; many option strikes remain above $65.73 (12/31/2024 close), tempering option exercise‑related selling near term .
  • Governance risk mitigants: Prohibitions on hedging/pledging, robust clawback, no excise tax gross‑ups, and strong say‑on‑pay support (93%) collectively reduce governance and compensation risk factors from an investor perspective .
  • Design evolution: 2024 and 2025 program changes increase rTSR‑linked PSUs and add innovation‑based PSUs (2025), tying more pay to shareholder outcomes and long‑term value creation; investors should monitor forward targets and disclosure of the innovation PSU to gauge rigor .